You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb1516392 |
---|---|
Category | Proteins |
Description | Recombinant human LIF protein (HEK293) |
Tag | Tag free |
Concentration | >0.5 mg/ml |
Form/Appearance | Lyophilized |
Purity | > 95% as determined by Tris-Bis PAGE; > 95% as determined by SEC-HPLC |
MW | Due to glycosylation, the protein migrates to 40-55 kDa based on Tris-Bis PAGE result. |
Target | Leukemia inhibitory factor |
Protein Sequence | 23-202/202 |
Expression System | HEK293 cell |
Biological Activity | Not tested |
Endotoxins | < 1.0 EU/μg as determined by LAL |
Storage | Stored at -70°C or -20°C. Avoid repeated freeze/thaw cycles. |
Buffer/Preservatives | Lyophilized from 0.22um filtered solution in PBS (pH7.4) with 5mM DTT. Normally 5% trehalose is added as protectant before Lyophilization. |
Alternative names | Leukemia inhibitory factor; DIA; CDF; Cholinergic Read more... |
Note | For research use only |
Application notes | Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
Expiration Date | 6 months from date of receipt. |
Human LIF Protein on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Immobilized Human LIF at 0.05 µg/ml (100 µl/Well). Dose response curve for Human LIF R, Fc Tag with the EC50 of 99.3 ng/ml determined by ELISA.
The purity of Human LIF Protein is greater than 95% as determined by SEC-HPLC.
> 95% as determined by Tris-Bis PAGE; > 95% as determined by SEC-HPLC | |
Due to glycosylation, the protein migrates to 120-140 kDa based on Tris-Bis PAGE result. |
98.00% | |
68.94 kDa (predicted). Due to glycosylation, the protein migrates to 80-110 kDa based on Tris-Bis PAGE result. |
97.90% | |
21.2 kDa (predicted); 35-42 kDa (reducing conditions) |
98.00% | |
46.7 kDa (predicted); 63 kDa (reducing conditions) |
SDS-PAGE: 99.5%; SEC-HPLC: 98.8% | |
19.7 kDa (predicted); 23-43 kDa (reducing condition, due to glycosylation) |